These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19802557)

  • 1. Acinetobacter spp as emerging pathogen in neonatal septicemia.
    Sharma M; Yadav S; Chaudhary U
    Indian J Pediatr; 2009 Aug; 76(8):861. PubMed ID: 19802557
    [No Abstract]   [Full Text] [Related]  

  • 2. Acinetobacter septicemia: a threat to neonates? Special aspects in a neonatal intensive care unit.
    Regev R; Dolfin T; Zelig I; Givoni S; Wolach B
    Infection; 1993; 21(6):394-6. PubMed ID: 8132370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is sulbactam really the answer for treatment of infections caused by multiresistant strains of Acinetobacter spp.?].
    Casellas JM; Dana R
    Enferm Infecc Microbiol Clin; 1997; 15(6):335-6. PubMed ID: 9376409
    [No Abstract]   [Full Text] [Related]  

  • 4. Acinetobacter lwoffii an emerging pathogen in neonatal ICU.
    Mittal S; Sharma M; Yadav A; Bala K; Chaudhary U
    Infect Disord Drug Targets; 2015; 15(3):184-8. PubMed ID: 26307173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acinetobacter spp. - an emerging pathogen in neonatal septicemia in Amritsar.
    Arora U; Jaitwani J
    Indian J Med Microbiol; 2006 Jan; 24(1):81. PubMed ID: 16505572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Microbiological aspects and problems of antibiotic resistance in sepsis due to Acinetobacter (Mimae)].
    Robert L; Piersantelli N
    Pathologica; 1971; 63(925):281-90. PubMed ID: 5155560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
    Valero E; Sevillano D; Calvo A; García R; Leturia A; Gómez-Lus ML
    Rev Esp Quimioter; 2001 Dec; 14(4):358-63. PubMed ID: 11856982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 9. Outbreak of Acinetobacter spp septicemia in a neonatal ICU.
    Mittal N; Nair D; Gupta N; Rawat D; Kabra S; Kumar S; Prakash SK; Sharma VK
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):365-6. PubMed ID: 12971564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First isolation of Acinetobacter johnsonii co-producing PER-2 and OXA-58 β-lactamases.
    Rodríguez CH; Nastro M; Dabos L; Barberis C; Vay C; Famiglietti A
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):341-2. PubMed ID: 25294301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intrahospital septicemia due to Acinetobacter calcoaceticus var. anitratus in a neonatal intensive care unit].
    Vivanco G; Figueroa A
    Rev Chil Pediatr; 1991; 62(5):297-301. PubMed ID: 1844938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3 cases of sepsis with drug resistant Acinetobacter anitratus].
    Yoshioka A; Unoki T; Nakamura I; Ishizaka H; Miyake H; Moroki J; Kunihiro M; Ueda N
    Kansenshogaku Zasshi; 1983 Sep; 57(9):828-34. PubMed ID: 6421962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microbiological and therapeutic considerations of Acinetobacter spp. infection].
    López-Brea M; Alarcón T; López S
    Rev Esp Quimioter; 1998 Jun; 11(2):110-7. PubMed ID: 9795295
    [No Abstract]   [Full Text] [Related]  

  • 14. Acinetobacter baumannii--an emerging nosocomial pathogen in the burns unit Manipal, India.
    Sengupta S; Kumar P; Ciraj AM; Shivananda PG
    Burns; 2001 Mar; 27(2):140-4. PubMed ID: 11226651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
    Park YK; Choi JY; Song JH; Ko KS
    Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518
    [No Abstract]   [Full Text] [Related]  

  • 16. Acinetobacter spp. and time-kill studies.
    Lopardo HA
    J Antimicrob Chemother; 2008 Feb; 61(2):464; author reply 464-6. PubMed ID: 18033781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acinetobacter calcoaceticus, a potential pathogen with an increasing role in pathology].
    Georgescu C; Neguţ M; Marinescu L; Călin C; Boboc F; Georgescu-Brăila M; Florescu DP; Trifan G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(4):333-9. PubMed ID: 6522946
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic and Clinical Characterization of IMP-1-Producing Multidrug-Resistant
    Tavares LCB; Cunha MPV; de Vasconcellos FM; Bertani AMJ; de Barcellos TAF; Bueno MS; Santos CA; Sant'Ana DA; Ferreira AM; Mondelli AL; Montelli AC; Sadatsune T; Sacchi CT; Gonçalves CR; Tiba-Casas MR; Camargo CH
    Microb Drug Resist; 2020 Nov; 26(11):1399-1404. PubMed ID: 32155381
    [No Abstract]   [Full Text] [Related]  

  • 19. Infection due to Mima-Herellea.
    Suwanraks C; Jayanetra P; Prachaktham R; Tejavej A
    J Med Assoc Thai; 1971 Nov; 54(11):849-57. PubMed ID: 5128925
    [No Abstract]   [Full Text] [Related]  

  • 20. Acinetobacter anitratus infections in man.
    Thong ML
    Aust N Z J Med; 1975 Oct; 5(5):435-9. PubMed ID: 1061546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.